Drug Type Recombinant protein |
Synonyms TEP 118, TEP-118 |
Target |
Action modulators |
Mechanism Hyaluronic acid modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Gallbladder Neoplasms | Preclinical | - | - | |
| Non-Small Cell Lung Cancer | Preclinical | - | - | |
| Stomach Cancer | Preclinical | - | - |






